Biosynex
Research Biosynex (ALBIO) on Bullrun: market cap EUR 16.77M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALBIO
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 16.77M
- Financial periodFY2025
- RevenueEUR 95.19M
- Revenue growth-5.9%
- Net income-EUR 58.22M
- Free cash flow-EUR 8.57M
- Gross margin55.0%
Valuation Snapshot
latest market cap is EUR 16.77M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 95.19M | -EUR 58.22M | -EUR 8.57M | 55.0% | -4.03 | EUR 8.46M | EUR 61.65M | EUR 34.95M |
| FY2024 | EUR 101.17M | -EUR 43.33M | -EUR 14.96M | 56.8% | -3.33 | EUR 4.69M | EUR 62.46M | EUR 80.58M |
| FY2023 | EUR 92.98M | -EUR 36.95M | -EUR 49.20M | 52.8% | -2.85 | EUR 20.17M | EUR 65.96M | EUR 124.48M |
| FY2022 | EUR 196.59M | EUR 15.66M | -EUR 32.83M | 52.1% | 1.26 | EUR 87.17M | EUR 52.08M | EUR 162.53M |
| FY2021 | EUR 382.53M | EUR 104.00M | EUR 90.82M | 54.0% | 8.27 | EUR 132.03M | EUR 35.16M | EUR 167.81M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 16.77M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
| Year | Dividends/share |
|---|---|
| FY2022 | 1.65 EUR |
| FY2021 | 0.17 EUR |
About Biosynex
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biosynex's market cap?
Biosynex's market capitalization is EUR 16.77M.
What does Biosynex do?
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray.